About the Cancer Grades and Cancer Stages Session
The size of a cancer and how far it has migrated from its origin are described by the cancer stage. The cancerous cell’s appearance is described by the grade. For different types of cancer, several staging systems are utilized.
- Stage 0 – signifies that the cancer hasn't spread from where it started (in situ).
- Stage I - the cancer is in its early stages and hasn't spread to other parts of the body.
- Stage II- the cancer has progressed but it has not spread.
- Stage III - the cancer has spread to the surrounding tissues and/or lymph nodes (which are part of the lymphatic system).
- Stage IV - cancer has spread to at least one other body organ from where it started; sometimes known as "secondary" or "metastatic" cancer.
The morphology of cancer cells under a microscope determines the cancer's grade. A lower grade often suggests a slower-growing cancer while a higher grade indicates a faster-growing cancer. The following are the most common grading system:
- Grade I - cancer cells that look and act like normal cells and aren't fast developing.
- Grade II - cancer cells that do not appear to be normal and develop at a faster pace than normal cells.
- Grade III - cancer cells that appear abnormal and have the potential to develop or spread more quickly.
The cancer's size, whether it has spread and the best treatment options will all be determined by staging and grading it.
- Grades of cancer and its detection
- Stages of cancer
Topics Covered in Cancer Grades and Cancer Stages
TNM Staging System
Histologic Grading
Carcinoma in Situ
Lymph Node Involvement
Distant Metastasis
Prognostic Stage Groups
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Grades and Cancer Stages Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Grades and Cancer Stages work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Grades and Cancer Stages research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Grades and Cancer Stages track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Grades and Cancer Stages Conference 2027 — FAQs
What is the Cancer Grades and Cancer Stages track at CIOC 2027?
The Cancer Grades and Cancer Stages track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Grades and Cancer Stages. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Grades and Cancer Stages sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Grades and Cancer Stages are all welcome — whether presenting or attending.
Can I present my research in the Cancer Grades and Cancer Stages track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Grades and Cancer Stages sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Grades and Cancer Stages track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.